Related references
Note: Only part of the references are listed.VASCULAR MECHANOTRANSDUCTION
Michael J. Davis et al.
PHYSIOLOGICAL REVIEWS (2023)
Targeting the KCa3.1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis
Xiao-Xin Jiang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Endothelial Ion Channels and Cell-Cell Communication in the Microcirculation
William F. Jackson
FRONTIERS IN PHYSIOLOGY (2022)
Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+-activated potassium channels
Valentina Back et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Endothelial shear stress signal transduction and atherogenesis: From mechanisms to therapeutics
Lei He et al.
PHARMACOLOGY & THERAPEUTICS (2022)
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Donald M. Lloyd -Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca2+ mobilization
Ramesh C. Mishra et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment
Mandy O. J. Grootaert et al.
CARDIOVASCULAR RESEARCH (2021)
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
Emily Herrett et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Amber N. Edinoff et al.
NEUROLOGY INTERNATIONAL (2021)
K(Ca)3.1 Inhibition Decreases Size and Alters Composition of Atherosclerotic Lesions Induced by Low, Oscillatory Flow
Darla L. Tharp et al.
ARTERY RESEARCH (2021)
SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging
Cini Mathew John et al.
PHARMACOLOGICAL RESEARCH (2020)
Treatment of coronarymicrovascular dysfunction
C. Noel Bairey Merz et al.
CARDIOVASCULAR RESEARCH (2020)
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A. Wood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Francois Mach et al.
ATHEROSCLEROSIS (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy et al.
CIRCULATION (2019)
Pharmacologic targeting of endothelial Ca2+-activated K+ channels: A strategy to improve cardiovascular function
Cini Mathew John et al.
CHANNELS (2018)
Endothelial dysfunction and angiogenesis impairment in the ageing vasculature
Zoltan Ungvari et al.
NATURE REVIEWS CARDIOLOGY (2018)
GABA(A) receptor: Positive and negative allosteric modulators
Richard W. Olsen
NEUROPHARMACOLOGY (2018)
Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures
Chia-Hsueh Lee et al.
SCIENCE (2018)
The Benzodiazepine Binding Sites of GABAA Receptors
Erwin Sigel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Physiological Roles and Therapeutic Potential of Ca2+ Activated Potassium Channels in the Nervous System
Aravind S. Kshatri et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Endothelial dysfunction and vascular disease - a 30th anniversary update
P. M. Vanhoutte et al.
ACTA PHYSIOLOGICA (2017)
Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d] oxazol-2-amine (SKA-121)
Brandon M. Brown et al.
MOLECULAR PHARMACOLOGY (2017)
The immunology of atherosclerosis
Anton Gistera et al.
NATURE REVIEWS NEPHROLOGY (2017)
MOLECULAR DETERMINANTS OF BK CHANNEL FUNCTIONAL DIVERSITY AND FUNCTIONING
Ramon Latorre et al.
PHYSIOLOGICAL REVIEWS (2017)
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels
Leonard K. Kaczmarek et al.
PHARMACOLOGICAL REVIEWS (2017)
The vascular endothelium: A regulator of arterial tone and interface for the immune system
Rayan Khaddaj Mallat et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
Shiraz Haron-Khun et al.
EMBO MOLECULAR MEDICINE (2017)
A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig model
Ramesh C. Mishra et al.
VASCULAR PHARMACOLOGY (2016)
Ion Channels in Innate and Adaptive Immunity
Stefan Feske et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Familial Hypercholesterolemia
Victoria Enchia Bouhairie et al.
CARDIOLOGY CLINICS (2015)
TRANSIENT RECEPTOR POTENTIAL CHANNELS IN THE VASCULATURE
Scott Earley et al.
PHYSIOLOGICAL REVIEWS (2015)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA
Nicole Schmitt et al.
PHYSIOLOGICAL REVIEWS (2014)
Regulation of Cellular Communication by Signaling Microdomains in the Blood Vessel Wall
Marie Billaud et al.
PHARMACOLOGICAL REVIEWS (2014)
Activation of K(Ca)3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice
Josephine Radtke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts
Ramesh C. Mishra et al.
CARDIOVASCULAR RESEARCH (2013)
The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo
Peter F. Davies et al.
CARDIOVASCULAR RESEARCH (2013)
A BK (Slo1) channel journey from molecule to physiology
Gustavo F. Contreras et al.
CHANNELS (2013)
The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling
Dan Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Clinton S. Robbins et al.
NATURE MEDICINE (2013)
LOX-1, OxLDL, and Atherosclerosis
Angela Pirillo et al.
MEDIATORS OF INFLAMMATION (2013)
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Peter Libby
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide
Paul M. Kerr et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?
Christiaan H. Vinkers et al.
ADVANCES IN PHARMACOLOGICAL SCIENCES (2012)
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)
Kenneth I. Ataga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
EDHF: spreading the influence of the endothelium
Christopher J. Garland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
Jeng-Jiann Chiu et al.
PHYSIOLOGICAL REVIEWS (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant
Abeer M. Al-Ghananeem et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Therapeutic potential of KCa3.1 blockers: recent advances and promising trends
Heike Wulff et al.
Expert Review of Clinical Pharmacology (2010)
The Endothelium and Its Role in Regulating Vascular Tone
Aamer Sandoo et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2010)
Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation
Jian-zhong Sheng et al.
FASEB JOURNAL (2009)
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure
Ananthakrishnan Sankaranarayanan et al.
MOLECULAR PHARMACOLOGY (2009)
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Peter F. Davies
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2009)
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
Kenneth I. Ataga et al.
BLOOD (2008)
Statins and the endothelium
Masaaki Ii et al.
VASCULAR PHARMACOLOGY (2007)
High-conductance potassium channels of the SLO family
Lawrence Salkoff et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Dose-escalation study of ICA-17043 in patients with sickle cell disease
Kenneth I. Ataga et al.
PHARMACOTHERAPY (2006)
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels
AD Wei et al.
PHARMACOLOGICAL REVIEWS (2005)
Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes
D Tuteja et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Role of endothelial dysfunction in atherosclerosis
J Davignon et al.
CIRCULATION (2004)
Molecular identification and functional roles of a Ca2+-activated K+ channel in human and mouse hearts
YF Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI
HM Crauwels et al.
CARDIOVASCULAR RESEARCH (2003)
Coupling between voltage sensor activation, Ca2+ binding and channel opening in large conductance (BK) potassium channels
FT Horrigan et al.
JOURNAL OF GENERAL PHYSIOLOGY (2002)
Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice
LV d'Uscio et al.
STROKE (2001)
Up-regulation of the IKCa1 potassium channel during T-cell activation -: Molecular mechanism and functional consequences
S Ghanshani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sustained endothelial nitric-oxide synthase activation requires capacitative Ca2+ entry
S Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
